Review



c8 opti lynx ii trap cartridge  (Optimize Technologies)


Bioz Verified Symbol Optimize Technologies is a verified supplier
Bioz Manufacturer Symbol Optimize Technologies manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Optimize Technologies c8 opti lynx ii trap cartridge
    C8 Opti Lynx Ii Trap Cartridge, supplied by Optimize Technologies, used in various techniques. Bioz Stars score: 93/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c8 opti lynx ii trap cartridge/product/Optimize Technologies
    Average 93 stars, based on 16 article reviews
    c8 opti lynx ii trap cartridge - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    95
    Protein Simple Inc simple plex cartridges
    Simple Plex Cartridges, supplied by Protein Simple Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/simple plex cartridges/product/Protein Simple Inc
    Average 95 stars, based on 1 article reviews
    simple plex cartridges - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    96
    FiberCell Systems c8008 hollow fiber cartridges
    C8008 Hollow Fiber Cartridges, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c8008 hollow fiber cartridges/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    c8008 hollow fiber cartridges - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    96
    FiberCell Systems medium 20kd mwco ps cartridge
    Medium 20kd Mwco Ps Cartridge, supplied by FiberCell Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/medium 20kd mwco ps cartridge/product/FiberCell Systems
    Average 96 stars, based on 1 article reviews
    medium 20kd mwco ps cartridge - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    93
    Optimize Technologies c8 opti lynx ii trap cartridge
    C8 Opti Lynx Ii Trap Cartridge, supplied by Optimize Technologies, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c8 opti lynx ii trap cartridge/product/Optimize Technologies
    Average 93 stars, based on 1 article reviews
    c8 opti lynx ii trap cartridge - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    97
    Teledyne LABS redisep silver column cartridges
    Redisep Silver Column Cartridges, supplied by Teledyne LABS, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/redisep silver column cartridges/product/Teledyne LABS
    Average 97 stars, based on 1 article reviews
    redisep silver column cartridges - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    99
    Fujirebio Inc lumipulse g plasma p tau217 immunoreaction cartridge kits
    Lumipulse <t>plasma</t> <t>p‐tau217</t> measurements, on (A) a linear scale and (B) a log10 scale, in renal function impairment samples (from the CN‐CKD cohort including samples at CKD stage 1 [ n = 11], stage 2 [ n = 15], stage 3a [ n = 16], stage 3b [ n = 9], stage 4 [ n = 7]) compared to AD and non‐AD samples (from the CSF cohort with AD [ n = 159], and non‐AD [ n = 98], box plots show median ± IQR; dotted lines represent the 0.153 and 0.422 pg/mL p‐tau217 cut‐points derived from the CSF cohort, P < 0.001 **** using a Wilcoxon signed‐rank test). AD, Alzheimer's disease; CN‐CKD, cognitively normal‐chronic kidney disease; CSF, cerebrospinal fluid; IQR, interquartile range; p‐tau, phosphorylated tau
    Lumipulse G Plasma P Tau217 Immunoreaction Cartridge Kits, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lumipulse g plasma p tau217 immunoreaction cartridge kits/product/Fujirebio Inc
    Average 99 stars, based on 1 article reviews
    lumipulse g plasma p tau217 immunoreaction cartridge kits - by Bioz Stars, 2026-03
    99/100 stars
      Buy from Supplier

    94
    Gyros Protein Technologies bioaffy 1000 hc compact disc microfluidic cartridges
    Lumipulse <t>plasma</t> <t>p‐tau217</t> measurements, on (A) a linear scale and (B) a log10 scale, in renal function impairment samples (from the CN‐CKD cohort including samples at CKD stage 1 [ n = 11], stage 2 [ n = 15], stage 3a [ n = 16], stage 3b [ n = 9], stage 4 [ n = 7]) compared to AD and non‐AD samples (from the CSF cohort with AD [ n = 159], and non‐AD [ n = 98], box plots show median ± IQR; dotted lines represent the 0.153 and 0.422 pg/mL p‐tau217 cut‐points derived from the CSF cohort, P < 0.001 **** using a Wilcoxon signed‐rank test). AD, Alzheimer's disease; CN‐CKD, cognitively normal‐chronic kidney disease; CSF, cerebrospinal fluid; IQR, interquartile range; p‐tau, phosphorylated tau
    Bioaffy 1000 Hc Compact Disc Microfluidic Cartridges, supplied by Gyros Protein Technologies, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bioaffy 1000 hc compact disc microfluidic cartridges/product/Gyros Protein Technologies
    Average 94 stars, based on 1 article reviews
    bioaffy 1000 hc compact disc microfluidic cartridges - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    Lumipulse plasma p‐tau217 measurements, on (A) a linear scale and (B) a log10 scale, in renal function impairment samples (from the CN‐CKD cohort including samples at CKD stage 1 [ n = 11], stage 2 [ n = 15], stage 3a [ n = 16], stage 3b [ n = 9], stage 4 [ n = 7]) compared to AD and non‐AD samples (from the CSF cohort with AD [ n = 159], and non‐AD [ n = 98], box plots show median ± IQR; dotted lines represent the 0.153 and 0.422 pg/mL p‐tau217 cut‐points derived from the CSF cohort, P < 0.001 **** using a Wilcoxon signed‐rank test). AD, Alzheimer's disease; CN‐CKD, cognitively normal‐chronic kidney disease; CSF, cerebrospinal fluid; IQR, interquartile range; p‐tau, phosphorylated tau

    Journal: Alzheimer's & Dementia

    Article Title: The Alzheimer's Disease Diagnosis and Plasma Phospho‐Tau217 (ADAPT) study stage 1: Validating clinical cut‐points against CSF and amyloid PET

    doi: 10.1002/alz.71147

    Figure Lengend Snippet: Lumipulse plasma p‐tau217 measurements, on (A) a linear scale and (B) a log10 scale, in renal function impairment samples (from the CN‐CKD cohort including samples at CKD stage 1 [ n = 11], stage 2 [ n = 15], stage 3a [ n = 16], stage 3b [ n = 9], stage 4 [ n = 7]) compared to AD and non‐AD samples (from the CSF cohort with AD [ n = 159], and non‐AD [ n = 98], box plots show median ± IQR; dotted lines represent the 0.153 and 0.422 pg/mL p‐tau217 cut‐points derived from the CSF cohort, P < 0.001 **** using a Wilcoxon signed‐rank test). AD, Alzheimer's disease; CN‐CKD, cognitively normal‐chronic kidney disease; CSF, cerebrospinal fluid; IQR, interquartile range; p‐tau, phosphorylated tau

    Article Snippet: Plasma samples were tested blinded in singlicate on the Lumipulse G1200 fully automated immunoassay platform using the commercially available Lumipulse G plasma p‐tau217 immunoreaction cartridge kits (Fujirebio Europe) according to manufacturer instructions.

    Techniques: Clinical Proteomics, Derivative Assay

    Relative change in concentration of plasma p‐tau217 across pre‐analytical sample handling conditions: (A) pre‐centrifugation delay at RT, (B) pre‐centrifugation delay at 2 to 8°C, (C) post‐centrifugation delay, (D) number of freeze–thaw cycles, compared to the baseline condition using the ALZpath and Lumipulse assays ( n = 10 per experiment, data presented as median ± IQR, dotted lines represent the lower and upper bounds of a 10% difference threshold from the baseline condition). IQR, interquartile range; p‐tau, phosphorylated tau; RT, room temperature

    Journal: Alzheimer's & Dementia

    Article Title: The Alzheimer's Disease Diagnosis and Plasma Phospho‐Tau217 (ADAPT) study stage 1: Validating clinical cut‐points against CSF and amyloid PET

    doi: 10.1002/alz.71147

    Figure Lengend Snippet: Relative change in concentration of plasma p‐tau217 across pre‐analytical sample handling conditions: (A) pre‐centrifugation delay at RT, (B) pre‐centrifugation delay at 2 to 8°C, (C) post‐centrifugation delay, (D) number of freeze–thaw cycles, compared to the baseline condition using the ALZpath and Lumipulse assays ( n = 10 per experiment, data presented as median ± IQR, dotted lines represent the lower and upper bounds of a 10% difference threshold from the baseline condition). IQR, interquartile range; p‐tau, phosphorylated tau; RT, room temperature

    Article Snippet: Plasma samples were tested blinded in singlicate on the Lumipulse G1200 fully automated immunoassay platform using the commercially available Lumipulse G plasma p‐tau217 immunoreaction cartridge kits (Fujirebio Europe) according to manufacturer instructions.

    Techniques: Concentration Assay, Clinical Proteomics, Analytical Sample Preparation, Centrifugation